MWM
NUVB icon

Meridian Wealth Management’s Nuvation Bio NUVB Stock Holding History

Meridian Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$751K Sell
132,256
-809
-0.6% -$3.95K 0.02% 444
2026
Q1 		$571K Buy
133,065
+19,500
+17% +$109K 0.02% 484
2025
Q4 		$1.02M Buy
113,565
+4,200
+4% +$26K 0.04% 348
2025
Q3 		$405K Buy
109,365
+22,250
+26% +$60.6K 0.02% 526
2025
Q2 		$170K Buy
87,115
+4,780
+6% +$9.96K 0.01% 649
2025
Q1 		$145K Sell
82,335
-2,505
-3% -$5.7K 0.01% 602
2024
Q4 		$226K Buy
84,840
+2,000
+2% +$5.15K 0.01% 581
2024
Q3 		$190K Buy
82,840
+26,495
+47% +$80.8K 0.01% 610
2024
Q2 		$165K Buy
+56,345
New +$172K 0.02% 278
2022
Q4 		– Sell
-11,850
Closed -$27K – 538
2022
Q3 		$27K Buy
11,850
+1,475
+14% +$4.21K ﹤0.01% 488
2022
Q2 		$34K Buy
+10,375
New +$45.2K ﹤0.01% 550

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Meridian Wealth Management's NUVB Position: Q2 2026 in Review

Meridian Wealth Management reduced its Nuvation Bio (NUVB) stake by 0.61% in Q2 2026, selling an estimated $3.95K and leaving 132,256 shares worth $751K. The position accounts for 0.02% of the portfolio, ranked #444.

Meridian Wealth Management first reported a position in NUVB in Q2 2022 and has held it in 11 quarters since. The position peaked at $1.02M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Meridian Wealth Management held 132,256 shares of Nuvation Bio worth $751K as of Q2 2026.
  • Meridian Wealth Management sold 809 Nuvation Bio shares in Q2 2026, an estimated $3.95K.
  • Nuvation Bio made up 0.02% of Meridian Wealth Management's portfolio in Q2 2026, its #444 holding.
  • Meridian Wealth Management first reported a position in Nuvation Bio in Q2 2022 and has held it in 11 quarters since.
  • Meridian Wealth Management's Nuvation Bio position peaked at $1.02M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.